Search alternatives:
significant part » significant gap (Expand Search), significant portion (Expand Search), significant factor (Expand Search)
part decrease » point decrease (Expand Search), bfrt decreased (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant part » significant gap (Expand Search), significant portion (Expand Search), significant factor (Expand Search)
part decrease » point decrease (Expand Search), bfrt decreased (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
261
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
262
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
263
-
264
-
265
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
266
-
267
-
268
-
269
-
270
-
271
-
272
Stepped wedge cluster randomized trial design.
Published 2025“…Peridomestic mosquito counts, BPN, and BPH did not differ significantly between renovated and non-renovated households. …”
-
273
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
-
274
-
275
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
276
-
277
-
278
-
279
-
280